IRIS
CANTINI, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.243
AS - Asia 807
EU - Europa 730
SA - Sud America 153
AF - Africa 86
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 4.025
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.207
SG - Singapore 360
CN - Cina 195
IT - Italia 148
BR - Brasile 134
HK - Hong Kong 106
DE - Germania 103
RU - Federazione Russa 97
IE - Irlanda 88
SE - Svezia 81
VN - Vietnam 65
GB - Regno Unito 58
CI - Costa d'Avorio 54
FI - Finlandia 41
IN - India 28
CA - Canada 26
FR - Francia 24
UA - Ucraina 24
MA - Marocco 18
PL - Polonia 17
JP - Giappone 13
BE - Belgio 11
ZA - Sudafrica 11
BD - Bangladesh 10
AR - Argentina 9
NL - Olanda 9
MX - Messico 8
CZ - Repubblica Ceca 7
IQ - Iraq 5
TR - Turchia 5
AT - Austria 4
DK - Danimarca 4
KR - Corea 4
EU - Europa 3
IL - Israele 3
RO - Romania 3
UZ - Uzbekistan 3
AU - Australia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
EC - Ecuador 2
EG - Egitto 2
ES - Italia 2
HN - Honduras 2
ID - Indonesia 2
LT - Lituania 2
PK - Pakistan 2
PY - Paraguay 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
OM - Oman 1
PH - Filippine 1
TN - Tunisia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.025
Salva come PNG Salva come JPEG
Città #
Ashburn 312
Chandler 265
Singapore 265
Des Moines 241
Dallas 126
Hong Kong 106
Fairfield 96
New York 90
Boardman 83
Dublin 83
Munich 75
Abidjan 54
Los Angeles 52
Ann Arbor 51
Beijing 50
Wilmington 45
Seattle 43
Woodbridge 39
Turku 35
Houston 34
Jacksonville 34
Cambridge 32
Lawrence 31
Princeton 31
Turin 29
Buffalo 25
San Mateo 25
San Diego 24
Santa Clara 23
Chicago 22
Hanoi 18
Ho Chi Minh City 18
Moscow 18
London 17
Warsaw 17
Montreal 16
Pune 16
The Dalles 14
Washington 14
Ancona 13
Rome 13
Atlanta 12
Brussels 11
Denver 11
Hefei 11
Johannesburg 11
São Paulo 11
Boston 10
Poplar 9
Salt Lake City 9
Tokyo 9
Shanghai 7
Urbisaglia 7
Amsterdam 6
Olomouc 6
Orem 6
Redmond 6
Shenzhen 6
Brasília 5
Brooklyn 5
Columbus 5
Elk Grove Village 5
Falls Church 5
Helsinki 5
Mexico City 5
Nuremberg 5
Rio de Janeiro 5
Stockholm 5
Tolentino 5
Wuhan 5
Zhengzhou 5
Arnold 4
Biên Hòa 4
Chennai 4
Guangzhou 4
Manchester 4
Ninh Bình 4
Phoenix 4
Qualiano 4
Baghdad 3
Belo Horizonte 3
Calgary 3
Charlotte 3
Curitiba 3
Da Nang 3
Fermignano 3
Frankfurt am Main 3
Mumbai 3
Prescot 3
St Petersburg 3
Sterling 3
Tashkent 3
Wuxi 3
Araçatuba 2
Baku 2
Bauru 2
Bellante 2
Bolton 2
Campo Verde 2
Caraguatatuba 2
Totale 2.896
Salva come PNG Salva come JPEG
Nome #
Are liver nested stromal epithelial tumors always low aggressive? 182
Impact of polypharmacy for chronic ailments in colon cancer patients: A review focused on drug repurposing. 163
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: a systematic review and meta-analysis 157
Optimal management of resected gastric cancer 152
BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma 151
Long‑responders to anti‑HER2 therapies: A case report and review of the literature 142
Role of DCE-MR imaging of the breast in predicting breast cancer subtypes: where are we going? 140
Acute Peripheral Motor Neuropathy Induced by Oxaliplatin-Correlated Hypokalaemia 137
Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients 134
Scientia Potentia Est: How the Italian World of Oncology Changes in the COVID-19 Pandemic 134
An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer 133
The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab 129
Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study 110
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy 110
Seroprevalence of SARS-CoV-2-Specific Antibodies in Cancer Patients Undergoing Active Systemic Treatment: A Single-Center Experience from the Marche Region, Italy 109
Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal Cancer 108
Prognostic Impact of Ki-67 Change in Locally Advanced and Early Breast Cancer after Neoadjuvant Chemotherapy: A Single Institution Experience 108
Old but gold: the role of drug combinations in improving response to immune check-point inhibitors in thoracic malignancies beyond NSCLC 107
Tumor burden as possible biomarker of outcome in advanced NSCLC patients treated with immunotherapy: a single center, retrospective, real-world analysis 105
Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer 105
Predictive ability of a drug-based score in patients with advanced non–small-cell lung cancer receiving first-line immunotherapy 102
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50% 100
Cancer patient perspective in the arena of COVID-19 pandemic 97
Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY study 91
Smoking status during first-line immunotherapy and chemotherapy in NSCLC patients: A case–control matched analysis from a large multicenter study 87
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research 85
Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study 83
Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients 79
The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer 79
Pachychoroid spectrum disease and choriocapillary flow analysis in patients with Cushing disease: an optical coherence tomography angiography study 79
Re: Comments on 'High-intensity statins are associated with improved clinical activity of programmed cell death protein 1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients' 78
Host immune-inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD-L1 ≥50% metastatic non-small cell lung cancer and poor performance status receiving first-line immunotherapy 74
Corrigendum to 'The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer': [ESMO Open Volume 6, Issue 2, April 2021, 100078] 73
High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status 73
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study 72
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study 57
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study 56
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study 50
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry 48
Persistence of long-term COVID-19 sequelae in patients with cancer: An analysis from the OnCovid registry 45
Totale 4.124
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.578
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.578
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021160 0 0 0 0 0 6 4 20 23 20 51 36
2021/2022276 3 26 5 6 17 34 13 15 48 16 36 57
2022/2023853 53 88 39 67 42 284 0 43 139 8 71 19
2023/2024405 67 9 28 32 48 127 2 8 0 17 5 62
2024/2025921 148 75 38 18 39 51 74 38 156 41 116 127
2025/20261.256 202 135 135 268 363 153 0 0 0 0 0 0
Totale 4.124